Db4 - Cost-Effectiveness of Dapagliflozin in Adult Patients With Inadequately Controlled Type 1 Diabetes: A Health Economic Analysis Using 24-Week Results From the Depict-1 Randomised Controlled Trial

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.040